- Home
- GNFT vs OSUR Comparison
GNFT vs OSUR Comparison
Compare GNFT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- OSUR
- Stock Information
- Founded
- GNFT 1999
- OSUR 2000
- Country
- GNFT France
- OSUR United States
- Employees
- GNFT N/A
- OSUR N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- OSUR Medical/Dental Instruments
- Sector
- GNFT Health Care
- OSUR Health Care
- Exchange
- GNFT Nasdaq
- OSUR Nasdaq
- Market Cap
- GNFT 296.4M
- OSUR 289.4M
- IPO Year
- GNFT 2019
- OSUR 1986
- Fundamental
- Price
- GNFT $4.00
- OSUR $3.84
- Analyst Decision
- GNFT Strong Buy
- OSUR Buy
- Analyst Count
- GNFT 1
- OSUR 3
- Target Price
- GNFT $13.00
- OSUR $6.67
- AVG Volume (30 Days)
- GNFT 7.6K
- OSUR 718.0K
- Earning Date
- GNFT 09-19-2024
- OSUR 11-06-2024
- Dividend Yield
- GNFT N/A
- OSUR N/A
- EPS Growth
- GNFT N/A
- OSUR N/A
- EPS
- GNFT 0.47
- OSUR 0.15
- Revenue
- GNFT $86,225,222.00
- OSUR $224,263,000.00
- Revenue This Year
- GNFT $155.44
- OSUR N/A
- Revenue Next Year
- GNFT N/A
- OSUR N/A
- P/E Ratio
- GNFT $8.62
- OSUR $25.16
- Revenue Growth
- GNFT 175.45
- OSUR N/A
- 52 Week Low
- GNFT $3.12
- OSUR $3.72
- 52 Week High
- GNFT $6.42
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- GNFT 24.93
- OSUR 41.36
- Support Level
- GNFT $4.17
- OSUR $3.80
- Resistance Level
- GNFT $4.41
- OSUR $4.03
- Average True Range (ATR)
- GNFT 0.11
- OSUR 0.14
- MACD
- GNFT -0.05
- OSUR -0.01
- Stochastic Oscillator
- GNFT 0.00
- OSUR 20.34
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.